GEM Premier 5000 and 7000 Recalled Over Barcode Reader Issue
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Instrumentation Laboratory is recalling 122 GEM Premier 5000 and GEM Premier 7000 portable blood analyzers nationwide due to potential incorrect patient ID assignment by affected barcode reader wands.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 13, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, medical-devices.
What Happened
Instrumentation Laboratory initiated a voluntary recall because Bar Code Reader (BCR) wands used with the GEM Premier 5000 and GEM Premier 7000 systems may assign patient results to an incorrect patient ID.
Which Products Are Affected
GEM Premier 5000 with iQM2 (Model/Catalog Number: 00024019255, UDI: 08426950870227) and GEM Premier 7000 with iQM3 (Model/Catalog Number: 00000015279, UDI: 0195226000924). Affected accessory: Bar Code Reader (BCR) Wand (Part No. 00024015859, UDI: 08426950869634) that received a configuration update on or after 8 April 2026. A total of 122 units are affected under recall number Z-2821-2026. Distribution was US Nationwide.
What You Should Do
The recall was initiated voluntarily by the firm via letter. No additional consumer instructions are provided in the recall data.
Why This Matters
The potential misassignment of patient results to incorrect IDs could impact the accuracy of blood analyzer readings used in medical settings.
Source
FDA Enforcement Report, recall number Z-2821-2026, report date 2026-08-05.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,083 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 13, 2026.
Frequently Asked Questions
Common questions about this FDA recall.